🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/06/2011 | 55,12 | 55,54 | 54,32 | 54,39 | -0,80% | 2,21% | 1.130.900 |
| 16/06/2011 | 55,34 | 55,56 | 54,18 | 54,83 | -0,47% | 2,49% | 963.900 |
| 15/06/2011 | 55,62 | 56,52 | 55,00 | 55,09 | -1,29% | 2,73% | 1.395.100 |
| 14/06/2011 | 55,99 | 56,45 | 55,47 | 55,81 | -0,18% | 1,75% | 1.181.200 |
| 13/06/2011 | 57,13 | 57,48 | 55,40 | 55,91 | -3,54% | 3,64% | 2.311.200 |
| 10/06/2011 | 59,01 | 59,37 | 57,87 | 57,96 | -2,44% | 2,54% | 1.180.900 |
| 09/06/2011 | 59,28 | 59,49 | 58,86 | 59,41 | +0,17% | 1,06% | 878.500 |
| 08/06/2011 | 59,20 | 59,63 | 58,81 | 59,31 | -0,34% | 1,39% | 928.600 |
| 07/06/2011 | 59,00 | 59,94 | 58,75 | 59,51 | +0,86% | 2,02% | 1.551.200 |
| 06/06/2011 | 59,20 | 60,35 | 58,37 | 59,00 | -5,90% | 3,34% | 5.079.200 |
| 03/06/2011 | 62,68 | 62,99 | 62,19 | 62,70 | -0,65% | 1,28% | 798.400 |
| 02/06/2011 | 63,65 | 63,68 | 62,56 | 63,11 | -0,74% | 1,76% | 1.523.300 |
| 01/06/2011 | 64,64 | 65,33 | 63,40 | 63,58 | -1,53% | 2,99% | 1.200.400 |
| 31/05/2011 | 64,96 | 65,37 | 63,61 | 64,57 | -0,22% | 2,71% | 1.052.800 |
| 27/05/2011 | 65,00 | 65,81 | 64,50 | 64,71 | -0,37% | 2,02% | 1.037.300 |
| 26/05/2011 | 64,62 | 65,27 | 64,13 | 64,95 | +0,48% | 1,76% | 835.200 |
| 25/05/2011 | 64,37 | 65,45 | 64,13 | 64,64 | -0,03% | 2,05% | 599.200 |
| 24/05/2011 | 64,65 | 64,96 | 64,19 | 64,66 | -0,02% | 1,19% | 429.500 |
| 23/05/2011 | 65,14 | 65,14 | 64,22 | 64,67 | -1,42% | 1,41% | 588.400 |
| 20/05/2011 | 66,20 | 66,43 | 65,00 | 65,60 | +0,51% | 2,16% | 809.400 |
| 19/05/2011 | 65,53 | 65,88 | 64,72 | 65,27 | -0,37% | 1,77% | 893.400 |
| 18/05/2011 | 65,36 | 65,80 | 64,99 | 65,51 | +0,63% | 1,24% | 684.600 |
| 17/05/2011 | 66,00 | 66,00 | 64,60 | 65,10 | -1,68% | 2,12% | 798.200 |
| 16/05/2011 | 66,97 | 67,35 | 66,11 | 66,21 | -1,60% | 1,85% | 702.700 |
| 13/05/2011 | 67,53 | 67,86 | 66,64 | 67,29 | -0,16% | 1,81% | 405.100 |
| 12/05/2011 | 67,19 | 67,68 | 66,85 | 67,40 | +0,13% | 1,24% | 879.000 |
| 11/05/2011 | 67,04 | 67,49 | 66,69 | 67,31 | +0,93% | 1,19% | 597.300 |
| 10/05/2011 | 66,57 | 66,82 | 65,76 | 66,69 | +0,50% | 1,59% | 678.800 |
| 09/05/2011 | 66,00 | 66,52 | 65,74 | 66,36 | +0,68% | 1,18% | 762.900 |
| 06/05/2011 | 66,62 | 66,80 | 65,66 | 65,91 | -0,36% | 1,71% | 1.005.400 |